Molecular and in vivo characterization of cancer-propagating cells derived from MYCN-dependent medulloblastoma.
Medulloblastoma (MB) is the most common malignant pediatric brain tumor. While the pathways that are deregulated in MB remain to be fully characterized, amplification and/or overexpression of the MYCN gene, which is has a critical role in cerebellar development as a regulator of neural progenitor ce...
Main Authors: | Zai Ahmad, Lukasz Jasnos, Veronica Gil, Louise Howell, Albert Hallsworth, Kevin Petrie, Tomoyuki Sawado, Louis Chesler |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4365014?pdf=render |
Similar Items
-
Biological Role of MYCN in Medulloblastoma: Novel Therapeutic Opportunities and Challenges Ahead
by: Sumana Shrestha, et al.
Published: (2021-06-01) -
miRNA expression profiling of the murine TH-MYCN neuroblastoma model reveals similarities with human tumors and identifies novel candidate miRNAs.
by: Marta Terrile, et al.
Published: (2011-01-01) -
SMAD9-MYCN positive feedback loop represents a unique dependency for MYCN-amplified neuroblastoma
by: Kezhe Tan, et al.
Published: (2022-12-01) -
MYCN and the Epigenome
by: Stanley eHe, et al.
Published: (2013-01-01) -
Targeting MYCN in Pediatric and Adult Cancers
by: Zhihui Liu, et al.
Published: (2021-02-01)